RVNC
Ensign Peak Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-67,332
| Closed | -$331K | – | 1741 |
|
|
2024
Q1 | $331K | Buy |
67,332
+16,982
| +34% | +$83.6K | ﹤0.01% | 1680 |
|
|
2023
Q4 | $443K | Buy |
50,350
+13,350
| +36% | +$117K | ﹤0.01% | 1679 |
|
|
2023
Q3 | $424K | Hold |
37,000
| – | – | ﹤0.01% | 1635 |
|
|
2023
Q2 | $936K | Hold |
37,000
| – | – | ﹤0.01% | 1315 |
|
|
2023
Q1 | $1.19M | Hold |
37,000
| – | – | ﹤0.01% | 1099 |
|
|
2022
Q4 | $683K | Buy |
37,000
+15,200
| +70% | +$281K | ﹤0.01% | 1475 |
|
|
2022
Q3 | $589K | Hold |
21,800
| – | – | ﹤0.01% | 1370 |
|
|
2022
Q2 | $301K | Hold |
21,800
| – | – | ﹤0.01% | 1684 |
|
|
2022
Q1 | $425K | Buy |
21,800
+8,570
| +65% | +$167K | ﹤0.01% | 1620 |
|
|
2021
Q4 | $216K | Buy |
+13,230
| New | +$216K | ﹤0.01% | 1909 |
|